Strategic Expansion Granules India is heavily investing in manufacturing facilities within Green Pharma City in Telangana, with a capital of $133 million for land acquisitions and advanced production capabilities, indicating a focus on expanding production capacity and developing required supply chain infrastructure.

Partnerships & Collaboration The company has recently partnered with NIPER and inaugurated a Centre of Excellence in Innovative and Sustainable Pharmaceutical Development, reflecting opportunities to collaborate on research, development, and new product innovation with research institutes.

Quality & Recognition Winning the EcoVadis Gold Medal demonstrates Granules India's strong commitment to sustainable and responsible manufacturing practices, positioning it as a trustworthy partner for clients prioritizing ESG factors.

Product Line & Market Focus Granules produces active pharmaceutical ingredients, formulation intermediates, and finished dosages, with distribution in over 80 countries, offering multiple entry points for sales of APIs and formulations in diverse markets.

Recent Acquisitions & Growth The acquisition of Swiss-based Senn Chemicals AG for CHF 20 million enhances Granules India's CDMO capabilities and geographic reach, creating new opportunities in high-value custom manufacturing and international collaboration.